COPD affects up to 1 in 10 adults over age 40

Key points
- Worldwide, up to 10 percent of adults aged 40 and older have lung impairment consistent with chronic obstructive pulmonary disease, or COPD, according to US researchers who analyzed published studied to quantify the global burden of COPD.
- COPD, a progressive lung illness that includes chronic bronchitis and emphysema, is characterized by airflow limitation that is not fully reversible.
- According to the World Health Organization, 75 percent of deaths from COPD that occur in developed countries are directly related to smoking tobacco.
- Ron Halbert from the UCLA School of Public Health in Los Angeles and colleagues identified more than 60 studies from 28 countries on COPD.
Worldwide, up to 10 percent of adults aged 40 and older have lung impairment consistent with chronic obstructive pulmonary disease, or COPD, according to US researchers who analyzed published studied to quantify the global burden of COPD.
COPD, a progressive lung illness that includes chronic bronchitis and emphysema, is characterized by airflow limitation that is not fully reversible. In addition to generating high healthcare costs, COPD is a leading cause of death and disability in developed countries.
Smoking is a key cause of COPD. According to the World Health Organization, 75 percent of deaths from COPD that occur in developed countries are directly related to smoking tobacco.
To gauge the global burden of COPD, Dr. Ron Halbert from the UCLA School of Public Health in Los Angeles and colleagues identified more than 60 studies from 28 countries on COPD.
Pooled results from 37 studies that used spirometry to measure COPD, the gold standard, put the prevalence of COPD at roughly 9 to 10 percent. "This is consistent with the range of 4 to 10 percent cited in a previous qualitative review," the team notes in the European Respiratory Journal.
As expected, COPD was more common in smokers, males, older adults, and persons living in urban areas.
"Unlike many leading causes of death and disability, COPD is projected to increase in much of the world as smoking frequencies rise and the population ages," warn Halbert and colleagues.
SOURCE: European Respiratory Journal, September 2006.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →
NewsLong-Term Antibiotics Reduce COPD Exacerbations, Raise Questions
Long-term use of a macrolide antibiotic may reduce the frequency of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) by as much as 35 percent, according to a London-based…
22 November 2008
NewsPersonalized therapy for asthma and COPD could soon be here
Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their…
19 May 2008
NewsNew Therapy Reduces Mortality in Patients with Severe COPD
Patients with severe COPD may benefit more from therapy that combines salmeterol and fluticasone [SFC] than treatment with tiotropium, according to results from a long-term, multi-center study, “Investigating New…